GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (TSXV:SBM) » Definitions » Cyclically Adjusted PB Ratio

Sirona Biochem (TSXV:SBM) Cyclically Adjusted PB Ratio : (As of May. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Sirona Biochem Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Sirona Biochem Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sirona Biochem's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Cyclically Adjusted PB Ratio Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.53 - - 19.79 23.07

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.56 25.34 22.60 23.07 36.89

Competitive Comparison of Sirona Biochem's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Sirona Biochem's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Biochem's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's Cyclically Adjusted PB Ratio falls into.



Sirona Biochem Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sirona Biochem's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Sirona Biochem's adjusted Book Value per Share data for the three months ended in Jan. 2024 was:

Adj_Book=Book Value per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=-0.011/125.0724*125.0724
=-0.011

Current CPI (Jan. 2024) = 125.0724.

Sirona Biochem Quarterly Data

Book Value per Share CPI Adj_Book
201404 0.020 98.920 0.025
201407 0.013 99.315 0.016
201410 0.013 99.473 0.016
201501 0.008 98.209 0.010
201504 0.011 99.710 0.014
201507 0.012 100.579 0.015
201510 0.014 100.500 0.017
201601 0.015 100.184 0.019
201604 0.016 101.370 0.020
201607 0.013 101.844 0.016
201610 0.009 102.002 0.011
201701 0.006 102.318 0.007
201704 0.002 103.029 0.002
201707 -0.001 103.029 -0.001
201710 -0.012 103.424 -0.015
201801 -0.012 104.056 -0.014
201804 -0.014 105.320 -0.017
201807 -0.014 106.110 -0.017
201810 -0.013 105.952 -0.015
201901 -0.016 105.557 -0.019
201904 -0.007 107.453 -0.008
201907 0.011 108.243 0.013
201910 0.010 107.927 0.012
202001 0.011 108.085 0.013
202004 0.008 107.216 0.009
202007 0.003 108.401 0.003
202010 0.000 108.638 0.000
202101 -0.002 109.192 -0.002
202104 -0.001 110.851 -0.001
202107 -0.003 112.431 -0.003
202110 0.000 113.695 0.000
202201 -0.002 114.801 -0.002
202204 0.003 118.357 0.003
202207 0.004 120.964 0.004
202210 0.001 121.517 0.001
202301 -0.001 121.596 -0.001
202304 -0.003 123.571 -0.003
202307 -0.005 124.914 -0.005
202310 -0.010 125.310 -0.010
202401 -0.011 125.072 -0.011

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sirona Biochem  (TSXV:SBM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sirona Biochem Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Biochem (TSXV:SBM) Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.
Executives
Howard Jarman Verrico Director, Senior Officer

Sirona Biochem (TSXV:SBM) Headlines